Report Detail
Global Postmenopausal Vaginal Atrophy Treatment Market Research Report 2012-2024
- RnM3628947 |
- 29 July, 2019 |
- Global |
- 85 Pages |
- HeyReport |
- Other
Summary
Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase.
The global Postmenopausal Vaginal Atrophy Treatment market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Creams
Tablets
Patches
Rings
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Allergan
Pfizer
Shionogi
Novo Nordisk
Teva Pharmaceutical
Bayer.
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Topical Estrogen
Systemic Estrogen
Non-hormonal Therapy
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Market Overview
- 1.1 Objectives of Research
- 1.1.1 Definition
- 1.1.2 Specifications
- 1.2 Market Segment
- 1.2.1 by Type
- 1.2.1.1 Creams
- 1.2.1.2 Tablets
- 1.2.1.3 Patches
- 1.2.1.4 Rings
- 1.2.2 by Application
- 1.2.2.1 Topical Estrogen
- 1.2.2.2 Systemic Estrogen
- 1.2.2.3 Non-hormonal Therapy
- 1.2.3 by Regions
- 1.2.1 by Type
2 Industry Chain
- 2.1 Industry Chain Structure
- 2.2 Upstream
- 2.3 Market
- 2.3.1 SWOT
- 2.3.2 Dynamics
3 Environmental Analysis
- 3.1 Policy
- 3.2 Economic
- 3.3 Technology
- 3.4 Market Entry
4 Market Segmentation by Type
- 4.1 Market Size
- 4.1.1 Creams Market, 2013-2018
- 4.1.2 Tablets Market, 2013-2018
- 4.1.3 Patches Market, 2013-2018
- 4.1.4 Rings Market, 2013-2018
- 4.2 Market Forecast
- 4.2.1 Creams Market Forecast, 2019-2024
- 4.2.2 Tablets Market Forecast, 2019-2024
- 4.2.3 Patches Market Forecast, 2019-2024
- 4.2.4 Rings Market Forecast, 2019-2024
5 Market Segmentation by Application
- 5.1 Market Size
- 5.1.1 Topical Estrogen Market, 2013-2018
- 5.1.2 Systemic Estrogen Market, 2013-2018
- 5.1.3 Non-hormonal Therapy Market, 2013-2018
- 5.2 Market Forecast
- 5.2.1 Topical Estrogen Market Forecast, 2019-2024
- 5.2.2 Systemic Estrogen Market Forecast, 2019-2024
- 5.2.3 Non-hormonal Therapy Market Forecast, 2019-2024
6 Market Segmentation by Region
- 6.1 Market Size
- 6.1.1 Asia-Pacific
- 6.1.1.1 Asia-Pacific Market, 2012-2018
- 6.1.1.2 Asia-Pacific Market by Type
- 6.1.1.3 Asia-Pacific Market by Application
- 6.1.2 North America
- 6.1.2.1 North America Market, 2012-2018
- 6.1.2.2 North America Market by Type
- 6.1.2.3 North America Market by Application
- 6.1.3 Europe
- 6.1.3.1 Europe Market, 2012-2018
- 6.1.3.2 Europe Market by Type
- 6.1.3.3 Europe Market by Application
- 6.1.4 South America
- 6.1.4.1 South America Market, 2012-2018
- 6.1.4.2 South America Market by Type
- 6.1.4.3 South America Market by Application
- 6.1.5 Middle East & Africa
- 6.1.5.1 Middle East & Africa Market, 2012-2018
- 6.1.5.2 Middle East & Africa Market by Type
- 6.1.5.3 Middle East & Africa Market by Application
- 6.1.1 Asia-Pacific
- 6.2 Market Forecast
- 6.2.1 Asia-Pacific Market Forecast, 2019-2024
- 6.2.2 North America Market Forecast, 2019-2024
- 6.2.3 Europe Market Forecast, 2019-2024
- 6.2.4 South America Market Forecast, 2019-2024
- 6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
- 7.1 Global Market by Vendors
- 7.2 Market Concentration
- 7.3 Price & Factors
- 7.4 Marketing Channel
8 Major Vendors
- 8.1 Allergan
- 8.2 Pfizer
- 8.3 Shionogi
- 8.4 Novo Nordisk
- 8.5 Teva Pharmaceutical
- 8.6 Bayer.
9 Conclusion
Summary:
Get latest Market Research Reports on Postmenopausal Vaginal Atrophy Treatment. Industry analysis & Market Report on Postmenopausal Vaginal Atrophy Treatment is a syndicated market report, published as Global Postmenopausal Vaginal Atrophy Treatment Market Research Report 2012-2024. It is complete Research Study and Industry Analysis of Postmenopausal Vaginal Atrophy Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
